Genocea Biosciences
GNCA
#11355
Rank
NZ$0.01 M
Marketcap
NZ$0.0001811
Share price
-85.71%
Change (1 day)
N/A
Change (1 year)

Earnings for Genocea Biosciences (GNCA)

Earnings in 2022 (TTM): -NZ$53.9 Million

According to Genocea Biosciences 's latest financial reports the company's current earnings are NZ$1.91 Million. In 2021 the company made an earning of -NZ$60.12 Million, an increase over its 2020 earnings that were of -NZ$79.16 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Genocea Biosciences from 2013 to 2022

Annual earnings

Year Earnings Change
2022 (TTM) -NZ$53.9 Million-10.34%
2021 -NZ$60.12 Million-24.06%
2020 -NZ$79.16 Million12.23%
2019 -NZ$70.54 Million40.05%
2018 -NZ$50.37 Million-50.96%
2017 -NZ$0.11 Billion14.4%
2016 -NZ$89.77 Million16.69%
2015 -NZ$76.93 Million20.36%
2014 -NZ$63.92 Million69.64%
2013 -NZ$37.68 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
NZ$12.61 B-18,835.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$12.17 B-18,176.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
-NZ$0.41 Billion 500.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
NZ$0.27 B-506.11%๐Ÿ‡บ๐Ÿ‡ธ USA
iBio
IBIO
-NZ$59.75 Million-11.29%๐Ÿ‡บ๐Ÿ‡ธ USA